Home Cart Sign in  
Chemical Structure| 150-38-9 Chemical Structure| 150-38-9

Structure of 150-38-9

Chemical Structure| 150-38-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ethylenediaminetetraacetic acid trisodium is used to bind metal ions in the practice of chelation therapy, for treating mercury and lead poisoning, used in a similar manner to remove excess iron from the body, for treating the complication of repeated blood transfusions, as would be applied to treat thalassaemia.

Synonyms: EDTA trisodium salt; Trisodium EDTA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ethylenediaminetetraacetic acid trisodium salt

CAS No. :150-38-9
Formula : C10H13N2Na3O8
M.W : 358.19
SMILES Code : [O-]C(CN(CCN(CC([O-])=O)CC(O)=O)CC([O-])=O)=O.[Na+].[Na+].[Na+]
Synonyms :
EDTA trisodium salt; Trisodium EDTA
MDL No. :MFCD00013305

Safety of Ethylenediaminetetraacetic acid trisodium salt

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302+H332-H318-H373
Precautionary Statements:P260-P264-P270-P271-P280-P301+P312+P330-P304+P340+P312-P305+P351+P338+P310-P314-P501

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03703739 Iron-deficiency Not Applicable Active, not recruiting December 2018 Switzerland ... More >> Human Nutrition Laboratory, ETH Zurich Zürich, Switzerland, 8092 Less <<
NCT02947022 - Terminated(PI left institution... More >>.) Less << - -
NCT00001575 - Completed - -
NCT00001575 Hodgkin's Disease ... More >> Lymphoma, Non-Hodgkin Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02947022 Headache Cogn... More >>itive Disturbance Skin Hyperpigmentation Arthralgia Less << Phase 1 Phase 2 Terminated(PI left institution... More >>.) Less << - United States, North Carolina ... More >> UNC Hospitals Chapel Hill, North Carolina, United States, 27599 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.79mL

0.56mL

0.28mL

13.96mL

2.79mL

1.40mL

27.92mL

5.58mL

2.79mL

 

Historical Records

Categories